GILEAD SCIENCES, S.L. secures contract for Pharmaceutical products Award of the Specific Contract for Medicines to treat HEPATITIS C derived from the Dynamic Acquisition System for the Supply of Exclusive Medicines for the Consorci Sanitari Integral

Spain, June 4 -- Spain based GILEAD SCIENCES, S.L. has secured contract from Consorci Sanitari Integral for Pharmaceutical products Award of the Specific Contract for Medicines to treat HEPATITIS C derived from the Dynamic Acquisition System for the Supply of Exclusive Medicines for the Consorci Sanitari Integral . The value of the contract is worth 81458588 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....